Related Experiment Video
Updated: Feb 21, 2026

06:50
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
3.1K
Human CCDC47 sandwich immunoassay development with electrochemiluminescence technology.
Wenfang S Wu1, Liang Zhu2, Saurabh Patil2
1BERG, LLC, 500 Old Connecticut Path, Framingham, MA 01701, USA; Department of Pathology, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA.
Journal of Immunological Methods
|October 5, 2017
Summary
Researchers developed sensitive assays to measure Coiled-Coil Domain Containing 47 (CCDC47), an endoplasmic reticulum protein involved in calcium signaling and stress relief. This advancement aids in studying CCDC47
Area of Science:
- Biochemistry
- Cell Biology
- Immunology
Background:
- Coiled-Coil Domain Containing 47 (CCDC47) is an endoplasmic reticulum (ER) transmembrane protein.
- CCDC47 plays roles in calcium signaling and endoplasmic reticulum-associated degradation (ERAD).
- CCDC47 is involved in ER stress relief mechanisms.
Purpose of the Study:
- To develop human CCDC47 monoclonal antibodies.
- To establish a sensitive sandwich immunoassay for CCDC47 quantification.
- To compare traditional ELISA with electrochemiluminescence (ECL) for enhanced analytical sensitivity.
Main Methods:
- Development and validation of monoclonal antibodies against human CCDC47.
- Specificity confirmation using immunoblot and liquid chromatography-tandem mass spectrometry (LC-MS/MS).
- Comparison of colorimetric ELISA and ECL immunoassay technologies.
- Development and performance evaluation of a CCDC47 sandwich ECL assay.
Main Results:
- Successfully developed and validated human CCDC47 monoclonal antibodies.
- Confirmed antibody specificity through immunoblot and LC-MS/MS.
- Achieved a 3-log increase in analytical sensitivity using ECL compared to traditional ELISA.
- Developed and characterized a robust CCDC47 sandwich ECL assay for biological matrices.
Conclusions:
- Human CCDC47 monoclonal antibodies and a sandwich ECL immunoassay have been successfully developed.
- The ECL assay offers significantly enhanced sensitivity for CCDC47 measurement.
- The developed assay is suitable for quantifying CCDC47 in biological samples, with characterized performance and stability.

